Validation of α-synuclein Modifications in Parkinson's dIsoRder Evolution

Abroad (travel likely)Recruiting

Conditions

Parkinson Disease (PD)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
Study leads
  • Marco Feligioni, PHD

    Study Chair

    EBRI-European Brain Research Insitute

  • Elda Judica, MD

    Principal Investigator

    Casa di Cura IGEA